Ranked #5,747 of 8,699 institutional investors
Foresite Capital Management IV, LLC
West Hollywood, CA
$230M
US stock portfolio at live prices · today +$1.2M (+0.51%)
Live prices, last trade 11:11 AM ET
- Value at quarter end (Q3 2026)
- $252M
- Change from Q2 2026
- −$38.1M (−13.14%)
- Positions
- 5 · 1 new, 0 sold out
- Filed
- Nov 16, 2026
Not counted in the ranking: none$152M of holdings we could not match to a US listing are included at their reported quarter-end value.
Holdings
Q3 2026 13F, live pricesCYTK 16.3%RLAY 8.79%EIKN 4.13%XENE 2.61%VCYT 2.16%
| Stock | Shares | Value, live | % of portfolio | vs Q2 2026 |
|---|---|---|---|---|
| CYTK Cytokinetics, Incorporated | 714,695 | $37.5M | 16.3% | Unchanged |
| RLAY Relay Therapeutics, Inc. | 1,250,000 | $20.2M | 8.79% | Unchanged |
| EIKN Eikon Therapeutics, Inc. | 1,943,682 | $9.5M | 4.13% | Unchanged |
| XENE Xenon Pharmaceuticals Inc. | 160,000 | $6.0M | 2.61% | Unchanged |
| VCYT Veracyte, Inc. | 200,000 | $5.0M | 2.16% | New |